Last reviewed · How we verify

Taxotere-Cisplatin-5FU

Swiss Cancer Institute · Phase 3 active Small molecule

Taxotere (docetaxel) works by inhibiting microtubule dynamics, disrupting cell division, and inducing apoptosis in cancer cells. Cisplatin is a platinum-based alkylating agent that cross-links DNA, causing DNA damage and triggering cell death. 5-Fluorouracil (5-FU) is a thymidylate synthase inhibitor that disrupts DNA synthesis and repair.

Taxotere (docetaxel) works by inhibiting microtubule dynamics, disrupting cell division, and inducing apoptosis in cancer cells. Cisplatin is a platinum-based alkylating agent that cross-links DNA, causing DNA damage and triggering cell death. 5-Fluorouracil (5-FU) is a thymidylate synthase inhibitor that disrupts DNA synthesis and repair. Used for Non-small cell lung cancer, Breast cancer, Stomach cancer.

At a glance

Generic nameTaxotere-Cisplatin-5FU
SponsorSwiss Cancer Institute
Drug classchemotherapy
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 3

Mechanism of action

Taxotere's mechanism of action involves binding to tubulin, preventing microtubule formation and function, which is essential for cell division. Cisplatin forms platinum-DNA adducts, leading to DNA damage and triggering cell death through apoptosis. 5-FU inhibits thymidylate synthase, an enzyme necessary for DNA synthesis and repair, thereby disrupting these processes and inducing cell death.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results